Drug Profile
Minocycline extended release - Sun Pharma
Alternative Names: XiminoLatest Information Update: 16 Oct 2021
Price :
$50
*
At a glance
- Originator Ranbaxy Laboratories
- Class Amides; Anti-inflammatories; Antiacnes; Antibacterials; Dimethylamines; Eye disorder therapies; Neuroprotectants; Skin disorder therapies; Small molecules; Tetracyclines
- Mechanism of Action Protein 30S ribosomal subunit inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Marketed Acne vulgaris
Most Recent Events
- 04 Nov 2017 No recent reports of development identified for clinical-Phase-Unknown development in Acne-vulgaris(In volunteers) in India (PO, Capsule)